Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...
TD Cowen downgraded Merck (MRK) to Hold from Buy with a price target of $100, down from $121. The firm says its Buy thesis “broke down” with Gardasil’s challenges in China. It is ...
Merck KGaA (MKGAY) confirms “advanced discussions” with Springworks Therapeutics (SWTX) regarding a potential acquisition. “Merck also confirms that no legally binding agreement has been ...
In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other dividend stocks. In this article, we will examine 10 companies with high dividend yields ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Standard treatment for stage III or stage IV clear cell renal cell carcinoma is surgery followed by immunotherapy with Merck's (MRK.N), opens new tab Keytruda. In most patients, however ...
During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...
Im Original ist das Quadrat nicht so scharf und die Ecken sind weniger rechtwinklig, was darauf hindeutet, dass sehr wahrscheinlich die Natur hier am Werk war. Bislang hat die Wissenschaft kein ...
SEC Filings provided by EDGAR Online, Inc.
In October, Merck took up an option on the personalised RNA-based cancer vaccine with an upfront payment of $250 million as part of a collaboration first agreed in 2016 and expanded in 2018.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und . Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MERCK & CO INC finden Sie auf Wallstreet Online.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback